Introduction
Astrocytes (Figure 1a ) are complex, highly differentiated cells that tile the entire central nervous system (CNS) in a contiguous fashion and make numerous essential contributions to normal function in the healthy CNS, including regulation of blood flow, provision of energy metabolites to neurons, participation in synaptic function and plasticity, and maintenance of the extracellular balance of ions, fluid balance and transmitters [1] [2] [3] [4] . In addition, astrocytes respond to all forms of CNS insults such as infection, trauma, ischemia and neurodegenerative disease by a process commonly referred to as reactive astrogliosis, which involves changes in their molecular expression and morphology (Figure 1b) , and in severe cases, scar formation ( Figure 1c ) [5] [6] [7] [8] [9] . In spite of the long-standing recognition that astrocytes have the potential to undergo these changes after CNS insults, and in spite of the ubiquitous presence of reactive astrocytes at all sites of CNS pathology, the functions and effects of reactive astrocytes are surprisingly poorly understood and their roles in specific disease processes are largely uncertain.
Perhaps the most well known aspect of reactive astrogliosis is that of scar formation. The ability of astrocytes to form scars that inhibit axon regeneration has been recognized for over 100 years and has led to an overall negative connotation that has long dominated concepts about the ramifications of reactive astrogliosis. Nevertheless, a growing body of information indicates that reactive astrocytes exert numerous essential beneficial functions and that astrocytes have a wide spectrum of potential, and often subtle, responses to CNS insults, of which scar formation is only one and lies at the extreme end in terms of its severity. This article summarizes recent advances in the molecular dissection of the functions and mechanisms of reactive astrogliosis, with the main focus on deletion experiments using transgenic mouse models that allow either cellular ablation or molecular deletion in combination with different types of injury or disease paradigms in vivo. This article begins with a definition and model of astrogliosis that includes surveys of molecules produced by reactive astrocytes and of triggering mechanisms and signaling pathways that regulate astrogliosis. It concludes with surveys of the functions of astrogliosis, the potential for dysfunction to contribute to disease mechanisms and the identification of novel therapeutic targets. Space constraints prevent exhaustive review of all topics and limit discussion to a cross-section of recent advances.
Defining reactive astrogliosis
What is astrogliosis? What features distinguish a reactive astrocyte from one that is non-reactive? Is astrogliosis an all-or-none process or a gradated one? Is it a good thing or bad? What are its molecular triggers or its functional consequences? Is astrogliosis synonymous with scar formation? Perhaps a majority of well-informed neurobiologists would be hard pressed to answer such questions. In spite of the increasing recognition that astrocytes play central roles in normal CNS function and that reactive astrocytes are primary responders to injury and disease, the concept of reactive astrogliosis seems generally elusive, with no commonly agreed upon definition or model. It is therefore useful to begin a review of recent studies into the functions and mechanisms of reactive astrogliosis by presenting a working model that defines various aspects of astrogliosis in a manner parsimonious with currently available information, while recognizing that any such model will require updating as new information accrues.
This article proposes a definition and model of 'reactive astrogliosis' that integrates four interdependent key features: (i) reactive astrogliosis is a spectrum of changes in astrocytes that occur in response to all forms and severities of CNS injury and disease including subtle perturbations; (ii) the changes undergone by reactive astrocytes vary with the nature and severity of the insult along a gradated continuum of progressive alterations in molecular expression, progressive cellular hypertrophy and, in severe cases, proliferation and scar formation (Figures 1 and 2) ; (iii) the changes of astrogliosis are regulated in a context-specific manner by specific signaling events that have the potential
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